dapi has been researched along with Parkinson Disease, Secondary in 3 studies
DAPI: RN given refers to parent cpd.
Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Richardson, RM | 1 |
| Broaddus, WC | 1 |
| Holloway, KL | 1 |
| Fillmore, HL | 1 |
| Imamura, K | 1 |
| Takeshima, T | 1 |
| Kashiwaya, Y | 1 |
| Nakaso, K | 1 |
| Nakashima, K | 1 |
| Paul, G | 1 |
| Christophersen, NS | 1 |
| Raymon, H | 1 |
| Kiaer, C | 1 |
| Smith, R | 1 |
| Brundin, P | 1 |
3 other studies available for dapi and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Grafts of adult subependymal zone neuronal progenitor cells rescue hemiparkinsonian behavioral decline.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Differentiation; Cell Movement; Cells | 2005 |
D-beta-hydroxybutyrate protects dopaminergic SH-SY5Y cells in a rotenone model of Parkinson's disease.
Topics: 3-Hydroxybutyric Acid; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Survival; Dopamine; Fluorescent | 2006 |
Tyrosine hydroxylase expression is unstable in a human immortalized mesencephalic cell line--studies in vitro and after intracerebral grafting in vivo.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain Tissue Transplantation; Cell Differentiation; | 2007 |